Companies: 10,795·Total market cap: $144.5T

eXoZymes, Inc.

eXoZymes, Inc.

EXOZNASDAQHealthcare● Active

$8.30

$-1.04(-11.13%)

Market Cap$70375634

P/E Ratio—

52W High$18.4

52W Low$7.08

Avg Volume5K

Open$9.00

Beta2.66

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

eXoZymes, Inc.（EXOZ）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · EXOZ · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.15Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding8.4MShares outstanding history

Next EarningsTBAEarnings history

探索 eXoZymes, Inc. 数据

分析师预测—

股息不分红

盈利EPS $-1.09-51.39%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$9.2M▼ 56.26% YoY

202320242025

FY 2025EPS$-1.09▼ 51.39% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$9.7MEPS: $-1.15View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$8.30-11.13%$70.4M #2

Anebulo Pharmaceuticals, Inc.

$0.36-6.64%$14.7M #3

Atossa Therapeutics, Inc.

$4.55+1.79%$39.2M #4

Cognition Therapeutics, Inc.

$1.21-6.20%$89.0M #5

Estrella Immunopharma, Inc.

$1.13-0.88%$48.6M #6

Greenwich LifeSciences, Inc.

$21.65-2.16%$317.8M

股票表现

1D-7.71%

1W-9.07%

1M-10.40%

3M+17.92%

YTD-20.92%

1Y-38.25%

5Y-0.35%

关于 eXoZymes, Inc.

CEOMichael Heltzen

IPO DateNov 13, 2024

Employees31

CountryUS

Websiteexozymes.com

eXoZymes, Inc. Operating within the United States, eXoZymes, Inc. is a pioneering synthetic biochemical enterprise. The company's primary innovation is SimplePath, a sophisticated platform engineered to synthesize a…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

eXoZymes, Inc.（EXOZ）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 13, 2024 在 NASDAQ 上市。截至最近交易日，EXOZ 股价为 $8.30，市值约为 $73.1M。过去12个月累计回报 -38.25%，年初至今回报 -20.92%。

2025 财年 eXoZymes, Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，eXoZymes, Inc.（EXOZ）股价为 $8.30，在 NASDAQ 上市，52周区间为 $7.08 – $18.40。

EXOZ 最新股价EXOZ quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议